There is emerging evidence that an increase in IL-17 level is closely associated with a range of inflammatory diseases including rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases, and psoriasis [14,15]. Here, IL17A is linked to inflammatory bowel disease.